Inimur

Nifuratel, the active ingredient in Inimur, is a nitrofuran presented as a vaginal formulation for vaginal use. It treats infections such as vaginal candidiasis, bacterial vaginosis and trichomoniasis in women. GNH USA supplies Inimur as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nifuratel is used to treat infections of the female genital tract, targeting bacterial and fungal pathogens. - Vaginal candidiasis: eliminates Candida species and relieves itching, discharge and irritation. - Bacterial vaginosis: reduces overgrowth of anaerobic bacteria and helps restore normal vaginal flora. - Trichomoniasis: eradicates Trichomonas vaginalis infection and clears associated symptoms.

Nifuratel may cause local or systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Local irritation: burning or itching at the application site. - Vaginal discharge: mild watery or whitish discharge. - Headache: transient mild headache. - Nausea: occasional mild nausea.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or anaphylaxis. - Severe vaginal inflammation: persistent ulceration or intense irritation. - Hepatic dysfunction: abnormal liver enzymes (rare).

Use of Inimur requires attention to several safety considerations. - Pregnancy: safety not established; use only if clearly needed. - Breastfeeding: unknown safety; weigh potential risks against benefits. - Allergies: avoid if hypersensitivity to nitrofurans is known. - Concomitant vaginal products: do not use other intravaginal medications simultaneously. - Medical conditions: caution in patients with liver disease. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Nifuratel may interact with other medicines, requiring awareness of potential effects.

Major Interactions (Avoid): - Antifungal azoles: may reduce the efficacy of Nifuratel. - Systemic antibiotics: concurrent use may alter vaginal flora and affect treatment outcome.

Moderate Interactions (Monitor Closely): - Hormonal contraceptives: vaginal irritation may affect absorption; monitor effectiveness. - Vaginal douches or spermicides: may interfere with drug action. - Immunosuppressants: monitor for increased infection risk.